Watchlists Portfolios Alerts Sign in Get started

Menu

CNCR

Range Cancer Therapeutics Index ETF

USD

Set alert

9.02 USD +0.14 +1.58%

As of May 27, 2025

9.02 Day range 9.41

11.86 52-week range 17.96

YTD: -26.73%
1 year: -34.26%

Open: 9.41
Prev close: 8.88
Mkt cap: 7.04M
Vol: 3.08K
Avg vol: 3.41K
EPS: 0.00
P/E: 0.00
Div yield: 0.00%

More statistics

Low: 9.02
High: 9.41
Forward P/E: 0.00
Beta: 0.00
Short ratio: 0.00
Dividend: 0.00
Ex-div date
50-d avg: 14.25
200-d avg: 14.74

Chart tools

Interval

Chart is warming up

The five-day price history for CNCR has not been loaded yet. Try again in a moment.

Issuer: —
Asset class: Equity
Expense ratio: 0.79%
Assets under management: $12.73M
NAV: 13.68
Holdings: 31
Inception: 2015-10-14
Top 10 weight: 34.44%

TIL Instil Bio, Inc. 3.59%
REPL Replimune Group, Inc. 3.54%
IOVA Iovance Biotherapeutics, Inc. 3.47%
ZYME Zymeworks Inc. 3.45%
ARGX argenx SE 3.42%
GMAB Genmab A/S 3.42%
BMY Bristol-Myers Squibb Company 3.39%
CRSP CRISPR Therapeutics AG 3.39%
AZN AstraZeneca PLC 3.39%
MRK Merck & Co., Inc. 3.37%
XNCR Xencor, Inc. 3.37%
NKTR Nektar Therapeutics 3.37%
REGN Regeneron Pharmaceuticals, Inc. 3.36%
GILD Gilead Sciences, Inc. 3.33%
FATE Fate Therapeutics, Inc. 3.33%
RCUS Arcus Biosciences, Inc. 3.32%
ATRA Atara Biotherapeutics, Inc. 3.30%
TRIL Trillium Therapeutics Inc. 3.29%
RUBY Rubius Therapeutics, Inc. 3.29%
ALLO Allogene Therapeutics, Inc. 3.29%
IBRX ImmunityBio, Inc. 3.28%
BLUE bluebird bio, Inc. 3.28%
IMAB I-Mab 3.25%
IGMS IGM Biosciences, Inc. 3.23%
STTK Shattuck Labs, Inc. 3.23%

Healthcare 96.58%
Financial Services 3.29%
Cash & Others 0.13%

United States 86.25%
Netherlands 3.42%
Denmark 3.42%
United Kingdom 3.39%
Switzerland 3.39%
Other 0.13%

Updated 2024-08-12

No holders on record

No holders on record

No insider holdings on record